Nouveau Life Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NOUV research report →
About the company
Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs.
- CEO
- Brian Shibley
- IPO
- 2003
- HQ
- Ft. Lauderdale, FL, US
Price Chart
- Market Cap
- $90.00K
- P/E
- -38.70
- P/S
- 0.00
- P/B
- 2.11
- EV/EBITDA
- -8.94
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 6.23%
- ROIC
- -2.84%
- Revenue
- $0 · 0.00%
- Net Income
- $-17,212 · 0.00%
- EPS
- $0.00 · 0.00%
- Op Income
- $-17,212
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.49
- Avg Volume
- 108.17K
Get TickerSpark's AI analysis on NOUV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NOUV coverage
Recent articles, reports, and earnings notes.
No research on NOUV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NOUV report →Similar companies
Peers in the same neighborhood.